---
title: Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
description: Discussion to Cover the Importance of Early-Stage CMC Testing in Enhancing Biologic Predictability, Scaling Up, and Accelerating Time to Market
---

[![Solvias Logo 2024](https://news.solvias.com/hs-fs/hubfs/identity/logos/Solvias%20Logo%202024.png?width=184&height=64&name=Solvias%20Logo%202024.png "Solvias Logo 2024")](https://solvias.com/)

[![Solvias Logo 2024](https://news.solvias.com/hs-fs/hubfs/identity/logos/Solvias%20Logo%202024.png?width=245&height=85&name=Solvias%20Logo%202024.png "Solvias Logo 2024")](https://us.solvias.com)

- [Expertise](https://www.solvias.com/expertise/)
- [Services](https://www.solvias.com/services/)
- [Products](https://www.solvias.com/products/)
- [Quality & Regulatory](https://www.solvias.com/quality-regulatory/)
- [About Us](https://www.solvias.com/about-us/)
- [Resources](https://www.solvias.com/resources/)

More results

[CONNECT WITH US](https://www.solvias.com/about-us/contact-us/)

[CONNECT WITH US](https://www.solvias.com/about-us/contact-us/)

[CONNECT WITH US](https://www.solvias.com/about-us/contact-us/)

- [Expertise](https://www.solvias.com/expertise/)
- [Services](https://www.solvias.com/services/)
- [Products](https://www.solvias.com/products/)
- [Quality & Regulatory](https://www.solvias.com/quality-regulatory/)
- [About Us](https://www.solvias.com/about-us/)
- [Resources](https://www.solvias.com/resources/)

- [Expertise](https://www.solvias.com/expertise/)
- [Services](https://www.solvias.com/services/)
- [Products](https://www.solvias.com/products/)
- [Quality & Regulatory](https://www.solvias.com/quality-regulatory/)
- [About Us](https://www.solvias.com/about-us/)
- [Resources](https://www.solvias.com/resources/)

<https://news.solvias.com/> News & Events

#### Share this

[Share on Twitter](https://twitter.com/share?url=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&text=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies) [Share on Facebook](https://www.facebook.com/sharer/sharer.php?u=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&t=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies) [Share on LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&t=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies)

# Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies

 by [**Solvias**](https://news.solvias.com/author/solvias) on Apr 22, 2025, 3:27:14 PM

## **Discussion to Cover the Importance of Early-Stage CMC Testing in Enhancing Biologic Predictability, Scaling Up, and Accelerating Time to Market**

KAISERAUGST, Switzerland - April 22, 2025 – Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, today announced that Christopher Hepler, Site Head at Solvias’ new Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park (RTP), NC, will be speaking at the Festival of Biologics, taking place April 23-24, 2025 in San Diego, CA. The annual Festival of Biologics conference brings together senior biologics professionals across the value chain to showcase their research, collaborate on challenges, forge new connections and ultimately advance the industry to improve patient health.

The session, titled, “Building Robust CMC Assays with Developability in Mind,” will underscore how robust CMC assays not only improve the predictability of biologics' behavior but also streamline scale-up processes, ensuring a smoother transition from clinical development to commercialization.

"Rigorous CMC testing plays a vital role in ensuring the stability, safety, and efficacy of large molecule therapeutics. By integrating early developability assessments and a data-driven approach, we can proactively address potential risks, enhance scalability, and reduce late-stage setback,” said Hepler. “I look forward to exploring how these strategies can accelerate the transition from clinical development to market, ultimately delivering innovative treatments to patients faster and more reliably.”

**Session information:**

- Presentation Session: CMC & Developability
- Presentation Topic: Building Robust CMC Assays with Developability in Mind
- Presentation Date/Time: Wednesday, April 23, 3:40 – 4:00 PM
- Location: Theater 5

Solvias launched the opening of its new [Center of Excellence for Biologics and Cell and Gene Therapy in RTP](https://eu1.hubs.ly/H0jqgh60) in January of this year. The new facility expanded Solvias’ global network to six centers of excellence, established a second hub in the U.S. in a growing biotech hub, and reinforced its commitment to advancing transformative therapies for cancer and rare diseases.

**About Solvias**     
Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life sciences industry. Its expert team combines decades of experience with regulatory expertise across small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release and API development for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards. For more information, visit [solvias.com](https://www.solvias.com/).    

**Media contact**  
Katy McGirr, Director of Global Marketing  
[Katy.mcgirr@solvias.com](mailto:Katy.mcgirr@solvias.com)  
+1 617 513 8287

Topics: [Press releases](https://news.solvias.com/tag/press-releases) [Corporate](https://news.solvias.com/tag/corporate)

#### Share this

[Share on Twitter](https://twitter.com/share?url=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&text=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies) [Share on Facebook](https://www.facebook.com/sharer/sharer.php?u=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&t=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies) [Share on LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies&t=Solvias%20to%20Speak%20at%20Festival%20of%20Biologics%202025%20on%20Building%20Robust%20CMC%20Assays%20for%20Biologic%20Therapies)

- Recent
- Topics
- Archive

Recent

Topics

- [Corporate (9)](https://news.solvias.com/tag/corporate)
- [Press releases (7)](https://news.solvias.com/tag/press-releases)
- [Large molecules (4)](https://news.solvias.com/tag/large-molecules)
- [Interviews (1)](https://news.solvias.com/tag/interviews)

Archive

- [March 2026 (1)](https://news.solvias.com/archive/2026/03)
- [May 2025 (1)](https://news.solvias.com/archive/2025/05)
- [April 2025 (1)](https://news.solvias.com/archive/2025/04)
- [March 2025 (1)](https://news.solvias.com/archive/2025/03)
- [January 2025 (1)](https://news.solvias.com/archive/2025/01)
- [July 2024 (1)](https://news.solvias.com/archive/2024/07)
- [May 2024 (1)](https://news.solvias.com/archive/2024/05)
- [January 2024 (2)](https://news.solvias.com/archive/2024/01)

See all

#### ![solvias\_logo\_2024\_color](https://news.solvias.com/hs-fs/hubfs/solvias_logo_2024_color.jpg?width=1550&height=540&name=solvias_logo_2024_color.jpg)

 

[info@solvias.com](mailto:info@solvias.com)

<https://www.linkedin.com/company/solvias-ag/><https://www.youtube.com/@SolviasAG>

- [Expertise](https://www.solvias.com/expertise/)
- [Services](https://www.solvias.com/services/)
- [Products](https://www.solvias.com/products/)
- [Quality & Regulatory](https://www.solvias.com/quality-regulatory/)
- [About Us](https://www.solvias.com/about-us/)
- [Resources](https://www.solvias.com/resources/)

 Copyright © 2026 Solvias.

- [Privacy Policy](https://www.solvias.com/privacy-policy/)
- [Accessibility Statement](https://www.solvias.com/accessibility-statement/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Solvias",
    "url" : "https://news.solvias.com/author/solvias"
  },
  "dateModified" : "2025-04-22T13:27:14.976Z",
  "datePublished" : "2025-04-22T13:27:14.000Z",
  "headline" : "Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies",
  "mainEntityOfPage" : {
    "@id" : "https://news.solvias.com/solvias-to-speak-at-festival-of-biologics-2025-on-building-robust-cmc-assays-for-biologic-therapies",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://news.solvias.com/hubfs/solvias_logo_2clr%20(3).png"
    }
  }
}
```